Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Dynamic Changes in MDS Clonal Architecture Following Allogeneic Stem Cell Transplant

Meagan A. Jacoby, MD PhD, Eric J. Duncavage, MD, Gue Su Chang, PhD, Christopher A. Miller, PhD, Jin Shao, Kevin Elliott, Robert S. Fulton, PhD, Catrina Fronick, Michelle O'Laughlin, Daniel C. Link, MD, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Timothy J. Ley, MD, Timothy A. Graubert, MD, Matthew J. Walter, MD, Richard K Wilson, PhD

Blood (2016) 128 (22): 5506.

https://doi.org/10.1182/blood.V128.22.5506.5506

Published: 2016

Journal Articles

Rare Pre-Existing MDS Subclones Contribute to Secondary AML Progression

Eric J. Duncavage, MD, Meagan A. Jacoby, MD PhD, Chris Miller, PhD, Gue Su Chang, PhD, Jin Shao, Kevin Elliot, Catrina Fronick, Michelle O'Laughlin, Robert Fulton, PhD, Richard K Wilson, PhD, Timothy A. Graubert, MD, Matthew J. Walter, MD

Blood (2016) 128 (22): 959.

https://doi.org/10.1182/blood.V128.22.959.959

Published: 2016

Journal Articles

Deleterious Germline Mutations in Telomere Maintenance Genes Identified in a Subset of Patients with Myelodysplastic Syndrome and Idiopathic Pulmonary Fibrosis

Kilannin Krysiak, PhD, Meagan A. Jacoby, MD PhD, Zachary L. Skidmore, MS, Arpad M. Danos, PhD, Michelle O'Laughlin, BS, Eric J. Duncavage, MD, Matthew J. Walter, MD, Malachi Griffith, PhD, Obi L. Griffith, PhD, Lukas D. Wartman, MD

Blood (2016) 128 (22): 4306.

https://doi.org/10.1182/blood.V128.22.4306.4306

Published: 2016

Journal Articles

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

Blood (2015) 126 (23): 689.

https://doi.org/10.1182/blood.V126.23.689.689

Published: 2015

Journal Articles

A Phase I Study of Vosaroxin Plus Azacitidine for Patients with Myelodysplastic Syndrome

Meagan A. Jacoby, MD PhD, Camille N. Abboud, MD FACP, John F Dipersio, MD PhD, Amanda F. Cashen, MD, Matthew J. Walter, MD, Rigoberto De Jesus Pizarro, Geoffrey L. Uy, MD

Blood (2015) 126 (23): 1686.

https://doi.org/10.1182/blood.V126.23.1686.1686

Published: 2015

Journal Articles

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Blood (2015) 126 (23): 610.

https://doi.org/10.1182/blood.V126.23.610.610

Published: 2015

Journal Articles

Detection of Clonal Hematopoiesis in Cytopenic Patients Using Targeted Sequencing

Eric J. Duncavage, MD, Jennifer O'Brien, MDPhD, Kiran R. Vij, MD, Chris A Miller, PhD, Jin Shao, Meagan A. Jacoby, MD PhD, Robert S. Fulton, PhD, Sharon Heath, Megan Janke, Catrina C. Fronick, Michelle O'Laughlin, Richard K Wilson, PhD, Timothy J. Ley, MD, Matthew J. Walter, MD

Blood (2015) 126 (23): 1654.

https://doi.org/10.1182/blood.V126.23.1654.1654

Published: 2015

Journal Articles

Use of Post-Transplant Cyclophosphamide (PTCy) with Mycophenolate Mofetil and Tacrolimus in HLA Matched Allogeneic Hematopoietic Cell Transplant Is Safe and Associated with Acceptable Transplant Outcomes

Brian T Hess, MD, Feng Gao, PhD, John F. DiPersio, MD PhD, Peter Westervelt, MD PhD, Ravi Vij, MD, Geoffrey L. Uy, MD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD FACP, Mark A. Schroeder, MD, Iskra Pusic, MD, Armin Ghobadi, MD, Amanda F. Cashen, MD, Todd A Fehniger, MD PhD, Meagan A. Jacoby, MD PhD, Rizwan Romee, MD

Blood (2015) 126 (23): 1950.

https://doi.org/10.1182/blood.V126.23.1950.1950

Published: 2015

Journal Articles

Safety, Efficacy, and Determination of the Recommended Phase 2 Dose for the Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330)

Blood (2015) 126 (23): 258.

https://doi.org/10.1182/blood.V126.23.258.258

Published: 2015

Journal Articles

A Phase I Study Of Azacitidine After Donor Lymphocyte Infusion For Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

Armin Ghobadi, MD, Mark A. Fiala, BS, CCRP, Camille N. Abboud, MD, Amanda F Cashen, MD, Linda Eissenberg, PhD, Timothy Graubert, MD, Meagan A Jacoby, MD/PhD, Iskra Pusic, MD, Mark A. Schroeder, MD, Keith E. Stockerl-Goldstein, MD, Michael H. Tomasson, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Matthew J. Walter, MD, John F. DiPersio, MD, PhD, Peter Westervelt, MD, PhD

Blood (2013) 122 (21): 3320.

https://doi.org/10.1182/blood.V122.21.3320.3320

Published: 2013

Journal Articles

Plerixafor, G-CSF and Azacitidine For The Treatment Of MDS: Results Of a Phase I Trial

Mark A. Schroeder, MD, Marcus Grillot, Teresa Reineck, Meagan A Jacoby, MD/PhD, Rizwan Romee, MD, Iskra Pusic, MD, John Welch, MD/PhD, Geoffrey L. Uy, MD, Amanda F Cashen, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MD, Shashikant Kulkarni, PhD, Peter Westervelt, MD, PhD, Matthew J. Walter, MD, John F. Dipersio, MD, PhD

Blood (2013) 122 (21): 2816.

https://doi.org/10.1182/blood.V122.21.2816.2816

Published: 2013

Journal Articles

Trisomy 8 Is Associated with Increased DNA Double Strand Breaks in Primary Myeloblasts

Meagan A Jacoby, MD/PhD, Rigoberto de Jesus, Matthew J. Walter, MD

Blood (2012) 120 (21): 3492.

https://doi.org/10.1182/blood.V120.21.3492.3492

Published: 2012

Journal Articles

Dysfunctional DNA Double-Strand Break Repair Is Present in a Subset of Primary t-AML/t-MDS Myeloblasts

Meagan A Jacoby, MD/PhD, Rigoberto de Jesus, Jin Shao, Daniel Koboldt, Matthew J. Walter, MD

Blood (2011) 118 (21): 2415.

https://doi.org/10.1182/blood.V118.21.2415.2415

Published: 2011

Journal Articles

Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older with Acute Myeloid Leukemia,

Meagan A Jacoby, MD/PhD, Michael Martin, Teresa Reineck, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Amanda Cashen, MD, Keith Stockerl-Goldstein, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Camille N. Abboud, MD

Blood (2011) 118 (21): 3633.

https://doi.org/10.1182/blood.V118.21.3633.3633

Published: 2011

Journal Articles

Dysfunctional Double-Strand DNA Break Repair In Primary t-AML/t-MDS Myeloblasts.

Meagan A Jacoby, MD/PhD, Rigoberto de Jesus, Matthew J. Walter, MD

Blood (2010) 116 (21): 3366.

https://doi.org/10.1182/blood.V116.21.3366.3366

Published: 2010

NARROW

Dynamic Changes in MDS Clonal Architecture Following Allogeneic Stem Cell Transplant

Rare Pre-Existing MDS Subclones Contribute to Secondary AML Progression

Deleterious Germline Mutations in Telomere Maintenance Genes Identified in a Subset of Patients with Myelodysplastic Syndrome and Idiopathic Pulmonary Fibrosis

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

A Phase I Study of Vosaroxin Plus Azacitidine for Patients with Myelodysplastic Syndrome

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Detection of Clonal Hematopoiesis in Cytopenic Patients Using Targeted Sequencing

Use of Post-Transplant Cyclophosphamide (PTCy) with Mycophenolate Mofetil and Tacrolimus in HLA Matched Allogeneic Hematopoietic Cell Transplant Is Safe and Associated with Acceptable Transplant Outcomes

Safety, Efficacy, and Determination of the Recommended Phase 2 Dose for the Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330)

A Phase I Study Of Azacitidine After Donor Lymphocyte Infusion For Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

Plerixafor, G-CSF and Azacitidine For The Treatment Of MDS: Results Of a Phase I Trial

Trisomy 8 Is Associated with Increased DNA Double Strand Breaks in Primary Myeloblasts

Dysfunctional DNA Double-Strand Break Repair Is Present in a Subset of Primary t-AML/t-MDS Myeloblasts

Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older with Acute Myeloid Leukemia,

Dysfunctional Double-Strand DNA Break Repair In Primary t-AML/t-MDS Myeloblasts.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only